Tuuli Lappalainen, PhD, is a Professor at KTH Royal Institute of Technology, the Director of the Genomics Platform and the National Genomics Infrastructure of SciLifeLab, Sweden, and an Associate Faculty Member at the New York Genome Center. Dr. Lappalainen received her PhD in Genetics from the University of Helsinki, followed by postdoctoral research at the University of Geneva and Stanford University. Her research focuses on functional genetic variation in human populations and its contribution to human traits and diseases, which her lab studies using both computational and experimental approaches.
She has pioneered in integrating large-scale genome and transcriptome sequencing data to understand how genetic variation affects gene expression, which gives insight to biological mechanisms underlying genetic disease risk. She has contributed to many of the most important international research consortia in human genetics, including the 1000 Genomes Project, the Geuvadis Consortium, the GTEx Project, MoTrPAC, and TOPMed. She is a principal investigator of numerous NIH grants and a recipient of the Leena Peltonen Prize for excellence in human genetics, and the Harold and Golden Lamport Award in Excellence in Basic Research.
